Bai L L, Xu T L, Zhang W Z, Jiang Y J, Zhou H J, Wu Y
National Institute for Communicable Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102206, China.
Zhonghua Yu Fang Yi Xue Za Zhi. 2025 Jul 6;59(7):982-988. doi: 10.3760/cma.j.cn112150-20240716-00573.
To identify candidate strains of Nontoxigenic (NTCD) with potential for intervention in infection (CDI) and analyze their phenotypic characteristics. A total of 713 strains from various sources were systematically collected nationwide between 2015 and 2023. This included 649 strains isolated from human fecal samples and 64 strains isolated from the fecal samples of farmed animals. NTCD strains were preliminarily screened through toxin gene detection and antibiotic sensitivity test, and then NTCD candidate strains with potential for intervention in CDI were screened by a series of in vitro experiments, including MLST, sporulation, germination, adhesion, motility, and biofilm formation ability. Ultimately, the virulence genes and antimicrobial resistance genes of the candidate strains were comprehensively analyzed to rigorously assess their safety profiles. Among 713 strains of from different sources, 10 strains were initially screened out, which were non-toxin-producing and sensitive to antibiotics. MLST showed that seven strains were from the Clade1 branch and three strains were of a novel type. The results of sporulation and germination showed that SD59, SD178, SJZ17, and WZ142 had stronger sporulation and germination abilities. The adhesion of 10 strains was high, and the adhesion rate was between 72.93% and 99.32%. The motility of all strains was different, and the motility of SD178, SD59 and SJZ17 was stronger. The biofilm-forming ability of all strains was weak. SD59, SD178 and SJZ17 carried a limited number of virulence and resistance genes, thereby posing a relatively low safety risk. Three NTCD strains are successfully selected as potential effective NTCD strains to interfere with CDI.
鉴定具有干预艰难梭菌感染(CDI)潜力的非产毒(NTCD)候选菌株,并分析其表型特征。2015年至2023年期间,在全国范围内系统收集了713株来自不同来源的菌株。其中包括从人类粪便样本中分离的649株和从养殖动物粪便样本中分离的64株。通过毒素基因检测和抗生素敏感性试验对NTCD菌株进行初步筛选,然后通过一系列体外实验,包括多位点序列分型(MLST)、芽孢形成、萌发、黏附、运动性和生物膜形成能力,筛选出具有干预CDI潜力的NTCD候选菌株。最终,对候选菌株的毒力基因和抗菌耐药基因进行综合分析,以严格评估其安全性。在713株来自不同来源的菌株中,初步筛选出10株不产毒素且对抗生素敏感的菌株。MLST显示,7株来自Clade1分支,3株为新型。芽孢形成和萌发结果表明,SD59、SD178、SJZ17和WZ142具有较强的芽孢形成和萌发能力。10株菌株的黏附性较高,黏附率在72.93%至99.32%之间。所有菌株的运动性各不相同,SD178、SD59和SJZ17的运动性较强。所有菌株的生物膜形成能力较弱。SD59、SD178和SJZ17携带的毒力和耐药基因数量有限,因此安全风险相对较低。成功筛选出3株NTCD菌株作为干预CDI的潜在有效NTCD菌株。